StockNews.com Begins Coverage on ContraFect (NASDAQ:CFRX)

StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Trading Down 28.0 % Shares of NASDAQ:CFRX opened at $0.05 on Thursday. ContraFect has a 12-month low of $0.04 and a 12-month high […]

Related Keywords

United States , ,Vanguard Group Inc ,Envestnet Asset Management Inc ,Dimensional Fund Advisors ,Goldman Sachs Group Inc ,Nasdaq ,Contrafect Corporation ,Free Report ,Fect Trading Down ,Get Free Report ,Asset Management ,Fund Advisors ,Street Corp ,Goldman Sachs Group ,Sachs Group ,Fect Corporation ,Contrafect Daily ,Contrafect ,Nasdaq Cfrx ,Cfrx ,Medical ,Initiated Coverage ,Stocknews Com ,